Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 AUD | -2.17% | -8.16% | -39.19% |
Feb. 29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
Feb. 29 | Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.19% | 13.19M | |
+25.61% | 660B | |
+23.66% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.68% | 219B | |
-9.94% | 196B | |
+6.78% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- RAD Stock
- News Radiopharm Theranostics Limited
- Radiopharm Theranostics Ends Phase 1 Breast Cancer Imaging Study; Shares Rise 3%